Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FF-10501-01 in Advanced Hematologic Malignancies
NCT02193958Phase 2Completed
- Sponsor
- Fujifilm Pharmaceuticals
- Start
- Jul 2014
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of FF-10501-01 in acute myeloid leukemia (AML), chronic myelomonocytic leukemia (CMML), myelodysplastic syndrome (MDS), sponsored by Fujifilm Pharmaceuticals. Started Jul 2014; status: completed.
02
Drugs
FF-10501-01
03
Conditions
acute myeloid leukemia (AML)chronic myelomonocytic leukemia (CMML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT02193958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02193958.